CHU Nîmes — Nîmes

Public research footprint of CHU Nîmes, compiled from the ClinicalTrials.gov public registry.

105

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Triple Negative Breast Cancer · Low Back Pain · Gastric/Gastro-esophageal Junction/Esophageal Adenocarcinoma · Metastatic Hormone-sensitive Prostate Cancer

Recently updated registry entries

NCT06225505 — Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE) (Recruiting)
NCT07718529 — Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK… (Not Yet Recruiting)
NCT05078047 — Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Nîmes?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.